José F. Rodríguez-Orengo to Viral Load
This is a "connection" page, showing publications José F. Rodríguez-Orengo has written about Viral Load.
Connection Strength
0.232
-
Rodr?guez-Torres M, Burguera J, Hallman D, Rodr?guez-Orengo J, Echeandia M. ?Hepatitis C viral kinetics in Latino patients: a comparison to African American and Caucasian patients. Ann Hepatol. 2012 Jul-Aug; 11(4):450-63.
Score: 0.094
-
Rodr?guez-Torres M, Rodr?guez-Orengo JF, R?os-Bedoya CF, Fern?ndez-Carbia A, Gonz?lez-Lassalle E, Salgado-Mercado R, Marxuach-Cu?tara AM. Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy. J Clin Virol. 2007 Jan; 38(1):32-8.
Score: 0.063
-
Br?u N, Salvatore M, R?os-Bedoya CF, Fern?ndez-Carbia A, Paronetto F, Rodr?guez-Orengo JF, Rodr?guez-Torres M. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol. 2006 Jan; 44(1):47-55.
Score: 0.058
-
Laspiur JP, Anderson ER, Ciborowski P, Wojna V, Rozek W, Duan F, Mayo R, Rodr?guez E, Plaud-Valent?n M, Rodr?guez-Orengo J, Gendelman HE, Mel?ndez LM. CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol. 2007 Dec; 192(1-2):157-70.
Score: 0.017